Publication: Estudio piloto sobre la expresión de Ciclina D1, Maspina, p21 y Ki-67 en lesiones orales potencialmente malgnizables y carcinomas orales de células escamosas
Loading...
Official URL
Full text at PDC
Publication Date
2017
Authors
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Citations
Exportar
Abstract
Description
UCM subjects
Unesco subjects
Keywords
Citation
(1) Poon RY. Cell Cycle Control: A System of Interlinking Oscillators. United States; 2016. p. 3-19.
(2) Otto T, Sicinski P. Cell cycle proteins as promising targets in cancer therapy. Nat Rev Cancer 2017; 17(2): 93-115.
(3) Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature 2004; 432(7015): 316-23.
(4) Todd R, Hinds PW, Munger K, Rustgi AK, Opitz OG, Suliman Y, et al. Cell cycle dysregulation in oral cancer. Crit Rev Oral Biol Med 2002; 13(1): 51-61.
(5) Lundberg AS, Weinberg RA. Control of the cell cycle and apoptosis. Eur J Cancer 1999 12; 35(14): 1886-94.
(6) Bretones G, Delgado MD, Leon J. Myc and cell cycle control. Biochim Biophys Acta; 1849(5): 506-16.
(7) Tang Z. Basic Properties of the Cell-Division Cycle. In: Coutts AS, Weston L, editors. Cell Cycle Oscillators (Methods and Protocols) New York Heidelberg Dordrecht London: Springer; 2016. p. 25.
(8) Kitagawa M, Kitagawa K, Kotake Y, Niida H, Ohhata T. Cell cycle regulation by long non-coding RNAs. Cell Mol Life Sci; 70(24): 4785-94.
(9) Aguilera A, Garcia-Muse T. Causes of genome instability. Annu Rev Genet 2013; 47: 1-32.
(10) McGregor F, Muntoni A, Fleming J, Brown J, Felix DH, MacDonald DG, et al. Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine. Cancer Res 2002; 62(16): 4757-66.
(11) Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100(1): 57-70.
(12) Scully C, Field JK, Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol 2000; 36(3): 256-63.
(13) Scully C, Field JK, Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations. Oral Oncol 2000; 36(4): 311-27.
(14) Scully C, Field JK, Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma 3: clinico-pathological applications. Oral Oncol 2000; 36(5): 404-13.
(15) Diaz-Moralli S, Tarrado-Castellarnau M, Miranda A, Cascante M. Targeting cell cycle regulation in cancer therapy. Pharmacol Ther 2013; 138(2): 255-71.
(16) Warnakulasuriya S, Johnson NW, van dW. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 2007; 36(10): 575-80.
(17) Cerero Lapiedra R, Baladé Martínez D, Moreno López LA, Esparza Gómez G, Bagán JV. Leucoplasia verrugosa proliferativa: propuesta de criterios diagnósticos. Med Oral Patol Oral Cir Bucal 2010; 15(5): 276-82.
(18) Van dW. Oral leukoplakia, the ongoing discussion on definition and terminology. Med Oral Patol Oral Cir Bucal 2015; 20(6): e685-92.
(19) Martínez DB, Martínez SL, Lapiedra RC, Gómez GE. Las lesiones blancas de la mucosa en el ámbito del precáncer oral. RCOE 2009; 14(2): 179-97.
(20) Gupta PC, Mehta FS, Daftary D, Pindborg J, Bhonsle R, Jalnawalla P, et al. Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10‐year follow‐up study of Indian villagers. Community Dent Oral Epidemiol 1980; 8(6): 287-333.
(21) Mincer HH, Coleman SA, Hopkins KP. Observations on the clinical characteristics of oral lesions showing histologic epithelial dysplasia. Oral Surgery, Oral Medicine, Oral Pathology 1972; 33(3): 389-99.
(22) Aguirre Echebarría P, Aguirre Urízar J. Displasia epitelial: Concepto y significación. Av Odontoestomatol 2008; 24(1): 81-8.
(23) Kujan O, Oliver RJ, Khattab A, Roberts SA, Thakker N, Sloan P. Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol 2006; 42(10): 987-93.
(24) El-Naggar A, Chang K, Grandis J, Takata T, Slootweg P. WHO Classification of Head and Neck Tumors. 4th ed. Lyon: IARC; 2017.
(25) Gale N, Pilch B, Sidransky D, El Naggar A, Westra W, Califano J. Epithelial precursors lesions. Pathology & Genetics Head and Neck Tumours. 1st ed. Lyon: IARC Press-WHO Press; 2005. p. 177-79.
(26) Hahn WC, Weinberg RA. Rules for making human tumor cells. N Engl J Med 2002; 347(20): 1593-1603.
(27) García García V, González-Moles M, Bascones Martínez A. Bases moleculares del cáncer oral: Revisión bibliográfica. Av Odontoestomatol 2005; 21(6): 287-95.
(28) Diez-Perez R, Campo-Trapero J, Cano-Sanchez J, Lopez-Durán M, Gonzalez-Moles M, Bascones-Ilundain J, et al. Methylation in oral cancer and pre-cancerous lesions. Oncol Rep 2011; 25(5): 1203-09.
(29) Femiano F, Scully C. DNA cytometry of oral leukoplakia and oral lichen planus. Med Oral Patol Oral Cir Bucal 2005; 10 (Suppl 1): E9-14.
(30) American Cancer Society. Cancer Facts & Figures 2016. Atlanta: American Cancer Society; 2016
(31) SEOM. La situación del cáncer en España/ El cáncer en España. Madrid (España): SEOM 2016.
(32) Lo Muzio L, Santarelli A, Panzarella V, Campisi G, Carella M, Ciavarella D, et al. Oral squamous cell carcinoma and biological markers: an update on the molecules mainly involved in oral carcinogenesis. Minerva Stomatol 2007; 56(6): 341-47.
(33) Lubin JH, Purdue M, Kelsey K, Zhang ZF, Winn D, Wei Q, et al. Total exposure and exposure rate effects for alcohol and smoking and risk of head and neck cancer: a pooled analysis of case-control studies. Am J Epidemiol 2009; 170(8): 937-47.
(34) Antón M, Somacarrera Pérez M. Càncer oral: genética, prevención, diagnóstico y tratamiento. Revisión de la literatura. Av Odontoestomatol 2015; 31(4): 247-59.
(35) Stewart B, Wild CP. World cancer report 2014. Health 2017.
(36) Ziober BL, Mauk MG, Falls EM, Chen Z, Ziober AF, Bau HH. Lab-on-a-chip for oral cancer screening and diagnosis. Head Neck 2008; 30(1): 111-21.
(37) Weinberg MA, Estefan DJ. Assessing oral malignancies. Am Fam Physician 2002; 65(7):1379-84.
(38) Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, et al. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet 2005; 365(9475): 1927-33.
(39) Massano J, Regateiro FS, Januário G, Ferreira A. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102(1): 67-76.
(40) Sudø¸ J, Reith A. The evolution of predictive oncology and molecular-based therapy for oral cancer prevention. Int J Cancer 2005; 115(3): 339-45.
(41) López-Durán M. Determinación de los perfiles de expresión de marcadores de senescencia en lesiones orales potencialmente malignizables y en carcinomas orales de células escamosas. [Tesis doctoral]. Madrid: Universidad Complutense de Madrid; 2016.
(42) Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25: 585-621.
(43) Campisi J, d'Adda dF. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8(9): 729-40.
(44) Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol 2011; 192(4): 547-56.
(45) Miura T, Mattson MP, Rao MS. Cellular lifespan and senescence signaling in embryonic stem cells. Aging Cell 2004; 3(6): 333-43.
(46) Beauséjour CM, Krtolica A, Galimi F, Narita M, Lowe SW, Yaswen P, et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J 2003; 22(16): 4212-22.
(47) Rayess H, Wang MB, Srivatsan ES. Cellular senescence and tumor suppressor gene p16. International journal of cancer 2012; 130(8): 1715-25.
(48) Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol 2013; 75: 685-705.
(49) Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965; 37: 614-36.
(50) Herbig U, Jobling WA, Chen BPC, Chen DJ, Sedivy JM. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21 (CIP1), but not p16 (INK4a). Mol Cell 2004; 14(4): 501-13.
(51) Kim S, Beauséjour C, Davalos AR, Kaminker P, Heo S, Campisi J. TIN2 mediates functions of TRF2 at human telomeres. J Biol Chem 2004; 279(42): 43799-804.
(52) Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 2005 05; 37(5): 961-76.
(53) Venable ME, Lee JY, Smyth MJ, Bielawska A, Obeid LM. Role of ceramide in cellular senescence. J Biol Chem 1995; 270(51): 30701-08.
(54) Daynes RA, Enioutina EY, Jones DC. Role of redox imbalance in the molecular mechanisms responsible for immunosenescence. Antioxid Redox Signal 2003; 5(5): 537-48.
(55) Lee AC, Fenster BE, Ito H, Takeda K, Bae NS, Hirai T, et al. Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem 1999; 274(12): 7936-40.
(56) Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88(5): 593-602.
(57) Prieur A, Peeper DS. Cellular senescence in vivo: a barrier to tumorigenesis. Curr Opin Cell Biol 2008; 20(2): 150-55.
(58) Kim Sh S, Kaminker P, Campisi J. Telomeres, aging and cancer: in search of a happy ending. Oncogene 2002; 21(4): 503-11.
(59) Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and aging. Cell 2007; 130(2): 223-33.
(60) Campo-Trapero J, Cano-Sánchez J, López-Durán M, Palacios-Sánchez B, Sánchez-Gutierrez J, Bascones-Martínez A. Marcadores de senescencia celular en cáncer y precáncer oral. Av Odontoestomatol 2008; 24(1): 69-80.
(61) Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, et al. Tumour biology: senescence in premalignant tumours. Nature 2005; 436(7051): 642.
(62) Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AHFM, Schlegelberger B, et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 2005; 436(7051): 660-65.
(63) Collado M, Serrano M. The power and the promise of oncogene-induced senescence markers. Nat Rev Cancer 2006; 6(6):472-76.
(64) Serrano M. Cancer: a lower bar for senescence. Nature 2010; 464(7287): 363-64.
(65) Collado M, Serrano M. Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 2010; 10(1): 51-7.
(66) Campisi J. Suppressing cancer: the importance of being senescent. Science 2005; 309(5736):886-87.
(67) Nickoloff BJ, Lingen MW, Chang B, Shen M, Swift M, Curry J, et al. Tumor suppressor maspin is up-regulated during keratinocyte senescence, exerting a paracrine antiangiogenic activity. Cancer Res 2004; 64(9): 2956-61.
(68) Guerra C, Collado M, Navas C, Schuhmacher AJ, Hernández-Porras I, Cañamero M, et al. Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell 2011; 19(6):728-39.
(69) Warnakulasuriya KA, Tavassoli M, Johnson NW. Relationship of p53 overexpression to other cell cycle regulatory proteins in oral squamous cell carcinoma. J Oral Pathol Med 1998; 27(8): 376-81.
(70) Itahana K, Campisi J, Dimri GP. Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay. Methods Mol Biol 2007; 371: 21-31.
(71) Sheng S. The promise and challenge toward the clinical application of maspin in cancer. Front Biosci 2004; 9: 2733-45.
(72) Marioni G, Gaio E, Giacomelli L, Bertolin A, D'Alessandro E, Stramare R, et al. MASPIN subcellular localization and expression in oral cavity squamous cell carcinoma. Eur Arch Otorhinolaryngol 2008; 265 Suppl 1: S97-S104.
(73) Iezzi G, Piattelli A, Rubini C, Goteri G, Artese L, Perrotti V, et al. Maspin expression in oral squamous cell carcinoma. J Craniofac Surg 2007; 18(5): 1039-43.
(74) Mohsin SK, Zhang M, Clark GM, Craig Allred D. Maspin expression in invasive breast cancer: association with other prognostic factors. J Pathol 2003; 199(4): 432-35.
(75) Takeda C, Takagi Y, Shiomi T, Nosaka K, Yamashita H, Osaki M, et al. Cytoplasmic maspin expression predicts poor prognosis of patients with soft tissue sarcomas. Diagn Pathol 2014; 9: 205.
(76) Reshma V, Rao K, Priya NS, Umadevi HS, Smitha T, Sheethal HS. Expression of maspin in benign and malignant salivary gland tumors: an immunohistochemical study. Indian J Dent Res 2014; 25(3): 346-51.
(77) Shay JW, Roninson IB. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 2004; 23(16): 2919-33.
(78) Schliephake H. Prognostic relevance of molecular markers of oral cancer-a review. Int J Oral Maxillofac Surg 2003; 32(3): 233-45.
(79) Papadimitrakopoulou V, Izzo JG, Liu DD, Myers J, Ceron TL, Lewin J, et al. Cyclin D1 and cancer development in laryngeal premalignancy patients. Cancer Prev Res (Phila) 2009; 2(1): 14-21.
(80) Liu H, Lu H, Lui M, Yu E, Shen W, Chen Y, et al. Detection of copy number amplification of cyclin D1 (CCND1) and cortactin (CTTN) in oral carcinoma and oral brushed samples from areca chewers. Oral Oncol 2009; 45(12): 1032-36.
(81) Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours: John Wiley & Sons; 2011.
(82) Prieto IP, Fenech AP, Martínez AB. Cáncer oral. Medicina clínica 2006; 127(7): 258-64.
(83) Gorgoulis VG, Halazonetis TD. Oncogene-induced senescence: the bright and dark side of the response. Curr Opin Cell Biol 2010; 22(6): 816-27.
(84) Golomb L, Sagiv A, Pateras IS, Maly A, Krizhanovsky V, Gorgoulis VG, et al. Age-associated inflammation connects RAS-induced senescence to stem cell dysfunction and epidermal malignancy. Cell Death Differ 2015; 22(11): 1764-74.
(85) Ohtani N, Mann DJ, Hara E. Cellular senescence: its role in tumor suppression and aging. Cancer science 2009; 100(5): 792-97.
(86) Bermejo M, Martínez A. Leucoplasia oral: Conceptos actuales/Oral Leukoplakia: Current considerations. Av Odontoestomatol 2009; 25(2): 83-97.
(87) Zhang L, Wu R, Dingle RC, Gairola CG, Valentino J, Swanson HI. Cigarette smoke condensate and dioxin suppress culture shock induced senescence in normal human oral keratinocytes. Oral Oncol 2007; 43(7): 693-700.
(88) García-García V, Bascones Martínez A. Cáncer oral: Puesta al día. Av Odontoestomatol 2009; 25(5): 239-48.
(89) Vázquez Álvarez R, Fernández González F, Gándara Vila P, Reboiras López D, García García A, Gándara Rey JM. Correlación clínico-patológica de la leucoplasia oral en una muestra de 54 pacientes. Med Oral Patol Oral Cir Bucal; 16(1): 15-20.
(90) Bascones-Martínez A, López-Durán M, Cano Sánchez J, Sánchez-Verde L, Díez-Rodríguez A, Aguirre-Echebarría P, et al. Differences in the expression of five senescence markers in oral cancer, oral leukoplakia and control samples in humans. Oncology letters 2012; 3(6): 1319-25.
(91) Nasser W, Flechtenmacher C, Holzinger D, Hofele C, Bosch FX. Aberrant expression of p53, p16INK4a and Ki‐67 as basic biomarker for malignant progression of oral leukoplakias. Journal of Oral Pathology & Medicine 2011; 40(8): 629-35.
(92) Perez-Sayans M, Suarez-Penaranda JM, Gayoso-Diz P, Barros-Angueira F, Gandara-Rey JM, Garcia-Garcia A. The role of p21Waf1/CIP1 as a Cip/Kip type cell-cycle regulator in oral squamous cell carcinoma (Review). Med Oral Patol Oral Cir Bucal 2013; 18(2): e219-25.
(93) Campisi J. Cancer, aging and cellular senescence. In Vivo 2000; 14(1): 183-88.
(94) Umekita Y, Yoshida H. Expression of maspin is up‐regulated during the progression of mammary ductal carcinoma. Histopathology 2003; 42(6): 541-45.
(95) Ghazy SE, Helmy IM, Baghdadi HM. Maspin and MCM2 immunoprofiling in salivary gland carcinomas. Diagn pathol 2011; 6(1): 89.
(96) Rau KM, Chen YJ, Sun MT, Kang HY. Prognostic effects and regulation of activin A, maspin, and the androgen receptor in upper urinary tract urothelial carcinoma. Anticancer Res 2011; 31(5): 1713-20.
(97) Queiroz AB, Focchi G, Dobo C, Gomes TS, Ribeiro DA, Oshima CT. Expression of p27, p21 (WAF/Cip1), and p16 (INK4a) in normal oral epithelium, oral squamous papilloma, and oral squamous cell carcinoma. Anticancer Res 2010; 30(7): 2799-2803.
(98) De Vicente JC, Herrero-Zapatero A, Fresno MF, López-Arranz JS. Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance. Oral Oncol 2002; 38(3): 301-8.
(99) Yoshizawa K, Nozaki S, Okamune A, Kitahara H, Ohara T, Kato K, et al. Loss of maspin is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma. Journal of oral pathology & medicine 2009; 38(6): 535-39.
(100) Abrahao AC, Bonelli BV, Nunes FD, Dias EP, Cabral MG. Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders. Brazilian oral research 2011; 25(1): 34-41.
(101) Harris SL, Thorne LB, Seaman WT, Neil Hayes D, Couch ME, Kimple RJ. Association of p16INK4a overexpression with improved outcomes in young patients with squamous cell cancers of the oral tongue. Head Neck 2011;